Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Mesa Laboratories (MLAB) over the last 16 years, with Q4 2025 value amounting to -$9.8 million.

  • Mesa Laboratories' Cash from Financing Activities rose 487.99% to -$9.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$42.3 million, marking a year-over-year decrease of 251.88%. This contributed to the annual value of -$44.5 million for FY2025, which is 23554.94% down from last year.
  • Per Mesa Laboratories' latest filing, its Cash from Financing Activities stood at -$9.8 million for Q4 2025, which was up 487.99% from -$7.9 million recorded in Q3 2025.
  • In the past 5 years, Mesa Laboratories' Cash from Financing Activities registered a high of $61.2 million during Q4 2021, and its lowest value of -$18.6 million during Q3 2022.
  • Its 5-year average for Cash from Financing Activities is -$978350.0, with a median of -$8.5 million in 2024.
  • In the last 5 years, Mesa Laboratories' Cash from Financing Activities skyrocketed by 3568947.37% in 2021 and then tumbled by 171019.0% in 2022.
  • Over the past 5 years, Mesa Laboratories' Cash from Financing Activities (Quarter) stood at $61.2 million in 2021, then tumbled by 114.51% to -$8.9 million in 2022, then surged by 784.99% to $60.8 million in 2023, then tumbled by 116.91% to -$10.3 million in 2024, then rose by 4.88% to -$9.8 million in 2025.
  • Its Cash from Financing Activities stands at -$9.8 million for Q4 2025, versus -$7.9 million for Q3 2025 and -$8.4 million for Q2 2025.